Following these outcomes, Sun Pharma has decided to discontinue further clinical trials of SCD-044 and has no plans for its ...

Sun Pharmaceutical Industries is discontinuing two trials of its drug candidate SCD-044 for moderate to severe as psoriasis ...

Stocks that offer high and secure dividends can be found particularly in Asia. In Switzerland, insurers and Julius Bär are among the top choices.

Rating upgraded from 85 to 91 Tuesday. Please watch the video at Investors.com - Find Top Growth Stocks With The IBD Screen ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...

FDG offers a concentrated, high-growth portfolio with mega-cap tech, consumer discretionary, and healthcare overweights, but ...

Alexandria Real Estate offers an unusually high 7.5% yield, at multi-decade low valuations. Click to read why ARE is rated ...

Nasus Pharma Ltd. ("Nasus Pharma" or the "Company"), a clinical-stage biopharmaceutical company focused on developing needle-free, powder-based intranasal ("PBI") products addressing acute, community ...

A short-lived bump in tariff-driven inflation could pass quickly enough to allow U.S. interest-rate cuts later this year, especially if tariffs themselves ease, Fed governor Christopher Waller said.

Biopharma Plastics Market. The global biopharma plastics market is projected to grow at a robust CAGR of 11.4% through 2033, ...

So far, China has made no official public threat about weaponizing its dominant position in this segment of the pharmaceutical industry. But Trump’s tariffs on the sector, if imposed, could worsen ...